Cardiosense
Chicago, US · Founded 2020 · 7 known investors
Cardiosense develops the CardioTag, a noninvasive point-of-care cardiac monitoring device that measures pulmonary capillary wedge pressure to enable early detection and management of worsening heart failure across emergency, inpatient, and outpatient settings. The solution uses wearable technology, signal processing, and AI to provide clinicians with objective hemodynamic data for treatment decisions.
Founders & leadership
JT
Jeff TerrellDirector
OT
Omer Tolga InanDirector
AK
Amit K. GuptaExecutive Officer, Director
AM
Andrew Michael CarekExecutive Officer
DG
Daniel GottliebDirector
Investors · 7
Reported raises · per SEC filings
Form D private placements▶$9.1MraisedDec 2022 · 28 investors · OtherRule 506(b)
▶$9.1MraisedDec 2022 · 28 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeff TerrellDirector
- Omer Tolga InanDirector
- Amit K. GuptaExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Offering amount
- $17.7M
- Amount sold
- $9.1M
- Minimum investment
- $20K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.